(Q43239052)

17 November 2017

title

Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity (English)

1 reference

17 November 2017

1 reference

5

1 reference

17 November 2017

6

1 reference

17 November 2017

7

1 reference

17 November 2017

V Hafner

1

1 reference

17 November 2017

M Jäger

series ordinal

2

1 reference

17 November 2017

A-K Matthée

series ordinal

3

1 reference

17 November 2017

R Ding

series ordinal

4

1 reference

17 November 2017

language of work or name

English

0 references

publication date

18 November 2009

1 reference

Clinical Pharmacology & Therapeutics

17 November 2017

published in

1 reference

17 November 2017

volume

87

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

191-196

1 reference

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

Differential impairment of triazolam and zolpidem clearance by ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

CYP induction-mediated drug interactions: in vitro assessment and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

What happens to long-term medication when general practice patients are referred to hospital?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Drug changes at the interface between primary and secondary care.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

The recovery time-course of CYP3A after induction by St John's wort administration

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Mechanism-based inactivation of CYP3A by HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Acute heart transplant rejection due to Saint John's wort

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.206

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.206

1 reference

17 November 2017

1 reference